CIK 0001819576 · Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851710962
- Phone
- 919.328.4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $23,494,367
- in 17 filings, $12.2M under 10b5-1 plans
Net −$23,494,367. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-15 | Kaseta Michael CFO and COO | Sale 10b5-1 | −43,375 | $40.14 | $1.7M | 353,356 |
| 2026-04-15 | Kaseta Michael CFO and COO | Option exercise · Incentive Stock Option (right to buy) 10b5-1 | −86,971 | 10,534 | ||
| 2026-04-14 | JEFFS ROGER Chief Executive Officer | Sale 10b5-1 | −3,300 | $40.00 | $132K | 1,491,934 |
| 2026-04-14 | Kaseta Michael CFO and COO | Option exercise 10b5-1 | +3,000 | $2.79 | $8K | 408,775 |
| 2026-04-14 | Kaseta Michael CFO and COO | Sale 10b5-1 | −3,000 | $40.00 | $120K | 405,775 |
| 2026-04-14 | Kaseta Michael CFO and COO | Option exercise · Incentive Stock Option (right to buy) 10b5-1 | −3,000 | 97,505 | ||
| 2026-04-13 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −8,861 | $38.37 | $340K | 186,244 |
| 2026-04-13 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −1,686 | $38.20 | $64K | 184,558 |
| 2026-04-13 | Adair Jason Chief Business Officer | Sale 10b5-1 | −7,301 | $38.37 | $280K | 215,426 |
| 2026-04-13 | Boyle Dana Chief Accounting Officer | Sale 10b5-1 | −5,101 | $38.37 | $196K | 176,918 |
| 2026-04-13 | Kaseta Michael CFO and COO | Sale 10b5-1 | −18,958 | $38.37 | $727K | 405,775 |
| 2026-04-13 | Krepp Sarah Chief Human Resource Officer | Sale | −4,557 | $38.37 | $175K | 147,019 |
| 2026-04-13 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −9,220 | $38.37 | $354K | 173,270 |
| 2026-04-13 | Schundler Russell General Counsel | Sale 10b5-1 | −13,692 | $38.37 | $525K | 610,532 |
| 2026-04-13 | JEFFS ROGER Chief Executive Officer | Sale 10b5-1 | −32,744 | $38.37 | $1.3M | 1,137,599 |
| 2026-04-10 | Moomaw Scott Chief Commercial Officer | Option exercise 10b5-1 | +3,107 | 190,747 | ||
| 2026-04-10 | Moomaw Scott Chief Commercial Officer | Option exercise 10b5-1 | +4,358 | 195,105 | ||
| 2026-04-10 | Moomaw Scott Chief Commercial Officer | Option exercise · Performance Stock Units 10b5-1 | −3,107 | 21,754 | ||
| 2026-04-10 | Moomaw Scott Chief Commercial Officer | Option exercise · Performance Stock Units 10b5-1 | −4,358 | 47,938 | ||
| 2026-04-10 | Adair Jason Chief Business Officer | Option exercise 10b5-1 | +3,906 | 216,385 |
Page 12 of 18 · 344 trades